Taris
A new paradigm in the treatment of bladder diseases
TARIS Pipeline
TARIS Biomedical is developing a portfolio of novel therapeutics designed to provide sustained, controlled-release of drug directly to the bladder for a wide array of bladder diseases.
The TARIS core technology lends itself to a variety of potential applications and TARIS is open to leveraging its technology and expertise to secure transforming product and research collaborations. Interested parties should contact: bd@tarisbio.com.
More Information
